IBDEI11O ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37894,1,3,0)
 ;;=3^Presence of xenogenic heart valve
 ;;^UTILITY(U,$J,358.3,37894,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,37894,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,37895,0)
 ;;=R21.^^140^1881^33
 ;;^UTILITY(U,$J,358.3,37895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37895,1,3,0)
 ;;=3^Rash & oth nonspecific skin eruption
 ;;^UTILITY(U,$J,358.3,37895,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,37895,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,37896,0)
 ;;=Z12.9^^140^1881^34
 ;;^UTILITY(U,$J,358.3,37896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37896,1,3,0)
 ;;=3^Screening malig neop site unspec
 ;;^UTILITY(U,$J,358.3,37896,1,4,0)
 ;;=4^Z12.9
 ;;^UTILITY(U,$J,358.3,37896,2)
 ;;=^5062698
 ;;^UTILITY(U,$J,358.3,37897,0)
 ;;=R06.02^^140^1881^35
 ;;^UTILITY(U,$J,358.3,37897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37897,1,3,0)
 ;;=3^Shortness of breath
 ;;^UTILITY(U,$J,358.3,37897,1,4,0)
 ;;=4^R06.02
 ;;^UTILITY(U,$J,358.3,37897,2)
 ;;=^5019181
 ;;^UTILITY(U,$J,358.3,37898,0)
 ;;=R00.0^^140^1881^40
 ;;^UTILITY(U,$J,358.3,37898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37898,1,3,0)
 ;;=3^Tachycardia, unspecified
 ;;^UTILITY(U,$J,358.3,37898,1,4,0)
 ;;=4^R00.0
 ;;^UTILITY(U,$J,358.3,37898,2)
 ;;=^5019163
 ;;^UTILITY(U,$J,358.3,37899,0)
 ;;=R32.^^140^1881^41
 ;;^UTILITY(U,$J,358.3,37899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37899,1,3,0)
 ;;=3^Urinary incontinence, unspec
 ;;^UTILITY(U,$J,358.3,37899,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,37899,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,37900,0)
 ;;=R33.9^^140^1881^42
 ;;^UTILITY(U,$J,358.3,37900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37900,1,3,0)
 ;;=3^Urine retention, unspec
 ;;^UTILITY(U,$J,358.3,37900,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,37900,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,37901,0)
 ;;=R53.1^^140^1881^43
 ;;^UTILITY(U,$J,358.3,37901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37901,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,37901,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,37901,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,37902,0)
 ;;=R63.4^^140^1881^44
 ;;^UTILITY(U,$J,358.3,37902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37902,1,3,0)
 ;;=3^Weight loss, abnormal
 ;;^UTILITY(U,$J,358.3,37902,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,37902,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,37903,0)
 ;;=I83.91^^140^1882^12
 ;;^UTILITY(U,$J,358.3,37903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37903,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,37903,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,37903,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,37904,0)
 ;;=I83.92^^140^1882^11
 ;;^UTILITY(U,$J,358.3,37904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37904,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,37904,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,37904,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,37905,0)
 ;;=I83.93^^140^1882^10
 ;;^UTILITY(U,$J,358.3,37905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37905,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
 ;;^UTILITY(U,$J,358.3,37905,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,37905,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,37906,0)
 ;;=I83.019^^140^1882^9
 ;;^UTILITY(U,$J,358.3,37906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37906,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,37906,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,37906,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,37907,0)
 ;;=I83.029^^140^1882^8
 ;;^UTILITY(U,$J,358.3,37907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37907,1,3,0)
 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,37907,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,37907,2)
 ;;=^5007986
 ;;^UTILITY(U,$J,358.3,37908,0)
 ;;=I71.4^^140^1882^1
 ;;^UTILITY(U,$J,358.3,37908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37908,1,3,0)
 ;;=3^AAA w/o rupture
 ;;^UTILITY(U,$J,358.3,37908,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,37908,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,37909,0)
 ;;=I73.9^^140^1882^3
 ;;^UTILITY(U,$J,358.3,37909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37909,1,3,0)
 ;;=3^PVD, unspec
 ;;^UTILITY(U,$J,358.3,37909,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,37909,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,37910,0)
 ;;=I80.201^^140^1882^4
 ;;^UTILITY(U,$J,358.3,37910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37910,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis deep vessels, right lower extremity
 ;;^UTILITY(U,$J,358.3,37910,1,4,0)
 ;;=4^I80.201
 ;;^UTILITY(U,$J,358.3,37910,2)
 ;;=^5007828
 ;;^UTILITY(U,$J,358.3,37911,0)
 ;;=I80.202^^140^1882^5
 ;;^UTILITY(U,$J,358.3,37911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37911,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis deep vessels, left lower extremities
 ;;^UTILITY(U,$J,358.3,37911,1,4,0)
 ;;=4^I80.202
 ;;^UTILITY(U,$J,358.3,37911,2)
 ;;=^5007829
 ;;^UTILITY(U,$J,358.3,37912,0)
 ;;=I80.203^^140^1882^6
 ;;^UTILITY(U,$J,358.3,37912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37912,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis deep vessels, bilateral lower extremities
 ;;^UTILITY(U,$J,358.3,37912,1,4,0)
 ;;=4^I80.203
 ;;^UTILITY(U,$J,358.3,37912,2)
 ;;=^5007830
 ;;^UTILITY(U,$J,358.3,37913,0)
 ;;=I80.3^^140^1882^7
 ;;^UTILITY(U,$J,358.3,37913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37913,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis of lower extremities, unspec
 ;;^UTILITY(U,$J,358.3,37913,1,4,0)
 ;;=4^I80.3
 ;;^UTILITY(U,$J,358.3,37913,2)
 ;;=^5007845
 ;;^UTILITY(U,$J,358.3,37914,0)
 ;;=I95.9^^140^1882^2
 ;;^UTILITY(U,$J,358.3,37914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37914,1,3,0)
 ;;=3^Hypotension, unspecified
 ;;^UTILITY(U,$J,358.3,37914,1,4,0)
 ;;=4^I95.9
 ;;^UTILITY(U,$J,358.3,37914,2)
 ;;=^5008080
 ;;^UTILITY(U,$J,358.3,37915,0)
 ;;=Z51.81^^140^1883^23
 ;;^UTILITY(U,$J,358.3,37915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37915,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,37915,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,37915,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,37916,0)
 ;;=D68.51^^140^1883^1
 ;;^UTILITY(U,$J,358.3,37916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37916,1,3,0)
 ;;=3^Activated Protein C Resistance
 ;;^UTILITY(U,$J,358.3,37916,1,4,0)
 ;;=4^D68.51
 ;;^UTILITY(U,$J,358.3,37916,2)
 ;;=^5002358
 ;;^UTILITY(U,$J,358.3,37917,0)
 ;;=I82.402^^140^1883^2
 ;;^UTILITY(U,$J,358.3,37917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37917,1,3,0)
 ;;=3^Acute Embolism/Thrombos Deep Veins Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,37917,1,4,0)
 ;;=4^I82.402
 ;;^UTILITY(U,$J,358.3,37917,2)
 ;;=^5007855
 ;;^UTILITY(U,$J,358.3,37918,0)
 ;;=I82.401^^140^1883^3
 ;;^UTILITY(U,$J,358.3,37918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37918,1,3,0)
 ;;=3^Acute Embolism/Thrombos Deep Veins Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,37918,1,4,0)
 ;;=4^I82.401
 ;;^UTILITY(U,$J,358.3,37918,2)
 ;;=^5007854
 ;;^UTILITY(U,$J,358.3,37919,0)
 ;;=I82.890^^140^1883^4
 ;;^UTILITY(U,$J,358.3,37919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37919,1,3,0)
 ;;=3^Acute Embolism/Thrombosis of Specified Veins
 ;;^UTILITY(U,$J,358.3,37919,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,37919,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,37920,0)
 ;;=D68.61^^140^1883^5
 ;;^UTILITY(U,$J,358.3,37920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37920,1,3,0)
 ;;=3^Antiphospholipid Syndrome
 ;;^UTILITY(U,$J,358.3,37920,1,4,0)
 ;;=4^D68.61
 ;;^UTILITY(U,$J,358.3,37920,2)
 ;;=^185421
 ;;^UTILITY(U,$J,358.3,37921,0)
 ;;=I63.50^^140^1883^6
 ;;^UTILITY(U,$J,358.3,37921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37921,1,3,0)
 ;;=3^Cerebral Infarction d/t Occls/Stenos of Cereb Artery
